Modulatory Effects of Gs-coupled Excitatory Opioid Receptor Functions on Opioid Analgesia, Tolerance, and Dependence

Overview

Journal Neurochem Res

Specialties Chemistry
Neurology

Date 1996 Nov 1

PMID 8947924

Citations 13

Authors

S M Crain

K F Shen

Affiliations

Soon will be listed here.

Abstract

Electrophysiologic studies of opioid effects on nociceptive types of dorsal root ganglion (DRG) neurons in organotypic cultures have shown that morphine and most mu, delta, and kappa opioid agonists can elicit bimodal excitatory as well as inhibitory modulation of the action potential duration (APD) of these cells. Excitatory opioid effects have been shown to be mediated by opioid receptors that are coupled via Gs to cyclic AMP-dependent ionic conductances that prolong the APD, whereas inhibitory opioid effects are mediated by opioid receptors coupled via Gi/Go to ionic conductances that shorten the APD. Selective blockade of excitatory opioid receptor functions by low (ca. pM) concentrations of naloxone, naltrexone, etorphine and other specific agents markedly increases the inhibitory potency of morphine or other bimodally acting agonists and attenuates development of tolerance/dependence. These in vitro studies have been confirmed by tail-flick assays showing that acute co-treatment of mice with morphine plus ultra-low-dose naltrexone or etorphine remarkably enhances the antinociceptive potency of morphine whereas chronic co-treatment attenuates development of tolerance and naloxone-precipitated withdrawal-jumping symptoms.

Citing Articles

Extrinsic and intrinsic control of striatal cholinergic interneuron activity.

Ratna D, Francis T Front Mol Neurosci. 2025; 18:1528419.

PMID: 40018010 PMC: 11865219. DOI: 10.3389/fnmol.2025.1528419.

The role of co-neurotransmitters in sleep and wake regulation.

Oh J, Petersen C, Walsh C, Bittencourt J, Neylan T, Grinberg L Mol Psychiatry. 2018; 24(9):1284-1295.

PMID: 30377299 PMC: 6491268. DOI: 10.1038/s41380-018-0291-2.

Opioid Activity in the Locus Coeruleus Is Modulated by Chronic Neuropathic Pain.

Llorca-Torralba M, Pilar-Cuellar F, Bravo L, Bruzos-Cidon C, Torrecilla M, Mico J Mol Neurobiol. 2018; 56(6):4135-4150.

PMID: 30284123 DOI: 10.1007/s12035-018-1361-9.

Genetic dissociation of morphine analgesia from hyperalgesia in mice.

Marrone G, Le Rouzic V, Varadi A, Xu J, Rajadhyaksha A, Majumdar S Psychopharmacology (Berl). 2017; 234(12):1891-1900.

PMID: 28343361 PMC: 5520541. DOI: 10.1007/s00213-017-4600-2.

Striatal cholinergic interneuron regulation and circuit effects.

Lim S, Kang U, McGehee D Front Synaptic Neurosci. 2014; 6:22.

PMID: 25374536 PMC: 4204445. DOI: 10.3389/fnsyn.2014.00022.

References

Crain S, Shen K . Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol Sci. 1990; 11(2):77-81. DOI: 10.1016/0165-6147(90)90322-y. View

Mudge A, Leeman S, Fischbach G . Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc Natl Acad Sci U S A. 1979; 76(1):526-30. PMC: 382975. DOI: 10.1073/pnas.76.1.526. View

Werz M, Macdonald R . Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration. J Pharmacol Exp Ther. 1985; 234(1):49-56. View

Crain S . Spinal cord tissue culture models for analyses of opioid analgesia, tolerance and plasticity. NIDA Res Monogr. 1984; 54:260-92. View

Shen K, Crain S . Biphalin, an enkephalin analog with unexpectedly high antinociceptive potency and low dependence liability in vivo, selectively antagonizes excitatory opioid receptor functions of sensory neurons in culture. Brain Res. 1995; 701(1-2):158-66. DOI: 10.1016/0006-8993(95)00999-1. View

Eason M, Kurose H, Holt B, Raymond J, Liggett S . Simultaneous coupling of alpha 2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of alpha 2C10, alpha 2C4, and alpha 2C2 adrenergic receptors to Gi and Gs. J Biol Chem. 1992; 267(22):15795-801. View

Shen K, Crain S . Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists. Brain Res. 1995; 673(1):30-8. DOI: 10.1016/0006-8993(94)01380-z. View

Horan P, Mattia A, Bilsky E, Weber S, Davis T, Yamamura H . Antinociceptive profile of biphalin, a dimeric enkephalin analog. J Pharmacol Exp Ther. 1993; 265(3):1446-54. View

Crain S, Shen K . Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci U S A. 1995; 92(23):10540-4. PMC: 40647. DOI: 10.1073/pnas.92.23.10540. View

10.

Shen K, Crain S . Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions. Brain Res. 1990; 531(1-2):1-7. DOI: 10.1016/0006-8993(90)90751-v. View

11.

Crain S, Crain B, Finnigan T, Simon E . Development of tolerance to opiates and opioid peptides in organotypic cultures of mouse spinal cord. Life Sci. 1979; 25(21):1797-802. DOI: 10.1016/0024-3205(79)90426-0. View

12.

Crain S, Crain B, MAKMAN M . Pertussis toxin blocks depressant effects of opioid, monoaminergic and muscarinic agonists on dorsal-horn network responses in spinal cord-ganglion cultures. Brain Res. 1987; 400(1):185-90. DOI: 10.1016/0006-8993(87)90670-6. View

13.

Crain S, Shen K . Etorphine elicits unique inhibitory-agonist and excitatory-antagonist actions at opioid receptors on sensory neurons: new rationale for improved clinical analgesia and treatment of opiate addiction. NIDA Res Monogr. 1995; 147:234-68. View

14.

Shen K, Crain S . Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors. Brain Res. 1990; 525(2):225-31. DOI: 10.1016/0006-8993(90)90868-c. View

15.

Crain S, Peterson E . Enhanced afferent synaptic functions in fetal mouse spinal cord-sensory ganglion explants following NGF-induced ganglion hypertrophy. Brain Res. 1974; 79(1):145-52. DOI: 10.1016/0006-8993(74)90574-5. View

16.

Shen K, Crain S . Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance. Brain Res. 1992; 597(1):74-83. DOI: 10.1016/0006-8993(92)91507-b. View

17.

Werz M, Macdonald R . Opioid peptides with differential affinity for mu and delta receptors decrease sensory neuron calcium-dependent action potentials. J Pharmacol Exp Ther. 1983; 227(2):394-402. View

18.

Shen K, Crain S . Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence. Brain Res. 1994; 636(2):286-97. DOI: 10.1016/0006-8993(94)91028-6. View

19.

Okamoto T, Murayama Y, Hayashi Y, Inagaki M, Ogata E, Nishimoto I . Identification of a Gs activator region of the beta 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell. 1991; 67(4):723-30. DOI: 10.1016/0092-8674(91)90067-9. View

20.

Nestler E . Molecular mechanisms of drug addiction. J Neurosci. 1992; 12(7):2439-50. PMC: 6575828. View